Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
Growth was broad-based across segments
The system is powered by BrainSense technology, which has received approval from USFDA
By cutting pain crises & boosting haemoglobin
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Subscribe To Our Newsletter & Stay Updated